$PBLS
Parabilis Medicines, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
PBLS chart
What traders are saying about $PBLS
Latest postsParabilis Medicines, Inc. news
- Parabilis Medicines: Bullish On Zolucatetide's Broad Oncology Potential (NASDAQ:PBLS)
Seeking Alpha ·
- Top Parabilis Medicines (PBLS) Competitors 2026
MarketBeat ·
- Parabilis Medicines, Inc. (PBLS) Discusses Updated Zolucatetide Data in Desmoid Tumors and Phase III Path - Slideshow (NASDAQ:PBLS) 2026-10-26
Seeking Alpha ·
- Parabilis Medicines announces safety, efficacy data for zolucatetide
TipRanks ·
- Parabilis Medicines, Inc. (PBLS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Parabilis Medicines, Inc. (PBLS) stock price, news, quote and history
Yahoo Finance UK ·
- Parabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027
marketbeat.com ·
- Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
Yahoo Finance ·
- No tumor growth was seen in 46 patients assessed in Parabilis' drug trial
Stock Titan ·
- Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ
Timothy Sykes ·
- Parabilis Medicines (NASDAQ:PBLS) Stock Price Down 7.7% - What's Next?
MarketBeat ·
- H.C. Wainwright initiates Parabilis Medicines stock coverage with buy rating
Investing.com ·
Parabilis Medicines, Inc. key financials
| USD | 2025 |
|---|---|
| Total assets (year end) | $80.8M |
| Cash and equivalents (year end) | $27.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Parabilis Medicines, Inc.
- Ticker
- PBLS (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1657677
- Former names
- FOG PHARMACEUTICALS, INC.
Frequently asked questions
What exchange is Parabilis Medicines, Inc. listed on?
Parabilis Medicines, Inc. trades on the Nasdaq under the ticker symbol PBLS.
What industry is Parabilis Medicines, Inc. in?
Parabilis Medicines, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Parabilis Medicines, Inc. headquartered?
Parabilis Medicines, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Parabilis Medicines, Inc.'s fiscal year end?
Parabilis Medicines, Inc.'s fiscal year ends on December 31.